SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028125
Filing Date
2018-11-07
Accepted
2018-11-07 17:16:24
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 GTHX-Q3-2018 10-Q gthx-10q_20180930.htm 10-Q 1097494
2 EX-31.1 gthx-ex311_8.htm EX-31.1 15857
3 EX-31.2 gthx-ex312_11.htm EX-31.2 15592
4 EX-32.1 gthx-ex321_7.htm EX-32.1 7314
5 EX-32.2 gthx-ex322_13.htm EX-32.2 7350
6 GRAPHIC g2nr4gonoeas000001.jpg GRAPHIC 1211
7 GRAPHIC g2nr4gonoeas000002.jpg GRAPHIC 1219
8 GRAPHIC g2nr4gonoeas000003.jpg GRAPHIC 1219
  Complete submission text file 0001564590-18-028125.txt   4136865

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT gthx-20180930.xml EX-101.INS 921014
10 XBRL TAXONOMY EXTENSION SCHEMA gthx-20180930.xsd EX-101.SCH 32658
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20180930_cal.xml EX-101.CAL 25445
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20180930_def.xml EX-101.DEF 78439
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20180930_lab.xml EX-101.LAB 242446
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20180930_pre.xml EX-101.PRE 182178
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 181167369
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1